These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6752436)

  • 1. EMIT-st drug detection system for screening of barbiturates and benzodiazepines in serum.
    Drost RH; Plomp TA; Maes RA
    J Toxicol Clin Toxicol; 1982 May; 19(3):303-12. PubMed ID: 6752436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New fluorescence polarization immunoassays for analysis of barbiturates and benzodiazepines in serum and urine: performance characteristics.
    Schwenzer KS; Pearlman R; Tsilimidos M; Salamone SJ; Cannon RC; Wong SH; Gock SB; Jentzen JJ
    J Anal Toxicol; 2000; 24(8):726-32. PubMed ID: 11110029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Criteria for the application of the EMIT-st system for screening of barbiturates and benzodiazepines in serum].
    Drost RH; Plomp TA; Maes RA
    Arch Farmacol Toxicol; 1984 Dec; 10(3):183-90. PubMed ID: 6398031
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanized toxicological serum tests in screening hospitalized patients.
    Hallbach J; Guder WG
    Eur J Clin Chem Clin Biochem; 1991 Sep; 29(9):537-47. PubMed ID: 1684724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Emit tox benzodiazepine and barbiturate assays on the Vitalab Viva analyser and FPIA on the Abbott ADx analyser.
    Charlier CJ; Plomteux GJ
    Clin Chem Lab Med; 2000 Jul; 38(7):615-8. PubMed ID: 11028766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the serum barbiturate fluorescence polarization immunoassay by the COBAS INTEGRA to a GC/MS method.
    Cannon RD; Wong SH; Gock SB; Jentzen JJ
    Ther Drug Monit; 1999 Oct; 21(5):553-8. PubMed ID: 10519455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of barbiturates by a modification of the EMIT-tox serum barbiturate assay.
    Watson AT; Manno JE; Manno BR
    J Anal Toxicol; 1983; 7(6):257-61. PubMed ID: 6363820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the EMIT Tox enzyme immunoassay for toxicological analysis of benzodiazepines in serum.
    Pegon Y; Pourcher E; Vallon JJ
    J Anal Toxicol; 1982; 6(1):1-3. PubMed ID: 7043087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for barbiturates in vitreous humor by the EMIT-st serum enzyme immunoassay.
    Ojanperä I; Vuori E; Nieminen R; Penttilä A
    J Forensic Sci; 1986 Apr; 31(2):707-9. PubMed ID: 3519837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The determination of drugs of abuse in whole blood by means of FPIA and EMIT-dau immunoassays--a comparative study.
    Bogusz M; Aderjan R; Schmitt G; Nadler E; Neureither B
    Forensic Sci Int; 1990 Nov; 48(1):27-37. PubMed ID: 2279719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of the EMIT tox benzodiazepine assay for screening of alprazolam in serum.
    Fraser AD; Bryan W; Isner AF
    J Anal Toxicol; 1988; 12(4):197-9. PubMed ID: 3054318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application and evaluation of the Emit-stTM drug detection system.
    Sutheimer C; Hepler BR; Sunshine I
    Am J Clin Pathol; 1982 Jun; 77(6):731-5. PubMed ID: 6124119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of amobarbital, butalbital, pentobarbital, phenobarbital, and secobarbital in urine, serum, and plasma using gas chromatography-mass spectrometry (GC-MS).
    Johnson LL; Garg U
    Methods Mol Biol; 2010; 603():65-74. PubMed ID: 20077060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the benzodiazepine plasma concentrations in suicidal patients using a radioreceptor assay.
    de Jong LA; Verwey B; Essink G; Muntendam A; Zitman FG; Ensing K
    J Anal Toxicol; 2004 Oct; 28(7):587-92. PubMed ID: 15516318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid tolerance and crosstolerance to motor impairment effects of benzodiazepines, barbiturates, and ethanol.
    Khanna JM; Kalant H; Chau A; Shah G
    Pharmacol Biochem Behav; 1998 Feb; 59(2):511-9. PubMed ID: 9477002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a rapid immunoassay for monitoring serum pentobarbital concentrations.
    Karnes HT; Iafrate RP; Gudat JC; Hendeles L
    Am J Hosp Pharm; 1984 Dec; 41(12):2642-6. PubMed ID: 6393759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abbott phencyclidine and barbiturates abused drug assays: evaluation and comparison of ADx FPIA, TDx FPIA, EMIT, and GC/MS methods.
    Caplan YH; Levine B
    J Anal Toxicol; 1989; 13(5):289-92. PubMed ID: 2693834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening for tetracyclic benzodiazepines using EMIT-st (benzodiazepines) and TDx].
    Schütz H; Schneider WR
    Z Rechtsmed; 1987; 99(3):181-9. PubMed ID: 2893500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of the Emit-dau system in the examination of cadaveric urine].
    Szathmary S; Daldrup T
    Z Rechtsmed; 1984; 92(2):101-7. PubMed ID: 6372310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of drugs of abuse detection in meconium by EMIT II and ELISA.
    Marin SJ; Keith L; Merrell M; McMillin GA
    J Anal Toxicol; 2009 Apr; 33(3):148-54. PubMed ID: 19371463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.